December newsletter is here! 3rd Annual EGFR Research Summit Overview, Grief/Coping Workshop Session on 12/9, $150K award from our EGFR Research Fund to study Tagrisso resistance, Lots of recent research updates on EGFR+ lung cancer —> https://t.co/NmiSBuZehphttps://t.co/El6VlGIDkj
We are a group of lung cancer patients with EGFR mutations who have developed resistance to at least one targeted treatment drug, or who face probable resistance in the future. Caregivers are also welcome. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.